Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-013904
Filing Date
2017-05-19
Accepted
2017-05-19 16:08:35
Documents
1
Period of Report
2017-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4792
  Complete submission text file 0000899243-17-013904.txt   6322
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Ekman Lars (Reporting) CIK: 0001376117 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 17857880

Mailing Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927
Business Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927 011-353-1-236-2500
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations